The Signal: Kivu Bioscience @nasdaq

The Signal: Kivu Bioscience @nasdaq

Uploaded August 2026 | Updated September 2026, 2 weeks ago

From breakthrough science to clinical milestones, Kivu Bioscience is advancing the future of oncology. Hear CEO Mohit Trikha discuss the company's innovative ADC platform and vision for improving cancer care on The Signal.

The Signal: Kivu Bioscience

Behind the Bell: MBX Biosciences

@SpaceX launches initial public offering on Nasdaq

Emma Grede on her personal and career growth

INNIO Group celebrates listing day at Nasdaq MarketSite

Lime celebrates their IPO at Nasdaq.

Bending Spoons becomes Nasdaq Listed

What Is Top of Mind for Clients Heading Into the US National Election?

Inference-first data strategy | Nasdaq TradeTalks

Allie K. Miller on communicating your goals to AI and having a goal-oriented mindset

Factorial Energy Co-Founder and CEO Dr. Siyu Huang shares $FACs vision for the future of energy.

Tabs CEO and Co-Founder on how AI is reshaping business operations

The Signal: Kivu Bioscience